Oral Oresentation 3

2:06 PM - 2:12 PM JST(5:06 AM - 5:12 AM UTC)

[O03-02] Comparison of clinical efficacy among ulcerative colitis patients treated with infliximab, vedolizumab, and ustekinumab as a first-line biologics: Evaluation based on adapted Mayo score

*Makoto Naganuma¹, Hisashi Shiga², Minoru Matsuura³, Kento Takenaka⁴, Toshimitsu Fujii⁴, Shojiro Yamamoto⁵, Mao Matsubayashi^6,7, Taku Kobayashi⁷, Tadakazu Hisamatsu³, UC-Bio Study Group (1. Third Department of Internal Medicine, Kansai Medical University, 2. Division of Gastroenterology, Tohoku University Graduate School of Medicine, 3. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, 4. Department of Gastroenterology and Hepatology, Institute of Science Tokyo, 5. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 6. Inflammatory Bowel Disease Center, Yokohama City University Medical Center, 7. Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.